You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Definition (free text, please give PubMed ID)
An abnormal formation of syncytium or symplasm, a multinucleate resulting from multiple cell fusions of uninuclear cells (i.e., cells with a single nucleus).
I think this is a little outside the scope of HPO, which is for clinical phenotypes. I think that this is an experimental observation that is not used at all in clinical contexts. I am not sure where the correct place is for this -- possibly it should go directly into Coronavirus Infectious Disease Ontology?
Preferred term label:
abnormal syncytia formation
https://en.wikipedia.org/wiki/Syncytium
Synonyms
abnormal syncytium
abnormal symplasm
Definition (free text, please give PubMed ID)
An abnormal formation of syncytium or symplasm, a multinucleate resulting from multiple cell fusions of uninuclear cells (i.e., cells with a single nucleus).
note: this is found in COVID-19:
https://www.embopress.org/doi/full/10.15252/embj.2020106267
Parent term (use hpo.jax.org/app)
Diseases characterized by this term ? (e.g. Orphanet or OMIM number)
SARS-CoV-2
https://www.embopress.org/doi/full/10.15252/embj.2020106267
(note: this is the term we would like to use in CIDO but it does not exist in HPO yet)
Your nano-attribution (ORCID)
http://orcid.org/0000-0001-9189-9661 (Oliver He)
Anthony Huffman and Oliver He
The text was updated successfully, but these errors were encountered: